(Q35947011)

English

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (English)

1 reference

Europe PubMed Central

11 August 2017

phase II clinical trial

0 references

cholangiocarcinoma

0 references

radiation therapy

0 references

1 reference

based on heuristic

inferred from title

Edgar Ben-Josef

1

object named as

Edgar Ben-Josef

0 references

Steven R Alberts

8

object named as

Steven R Alberts

1 reference

Europe PubMed Central

11 August 2017

author name string

Katherine A Guthrie

2

1 reference

Europe PubMed Central

11 August 2017

Anthony B El-Khoueiry

3

1 reference

Europe PubMed Central

11 August 2017

Christopher L Corless

4

1 reference

Europe PubMed Central

11 August 2017

Mark M Zalupski

5

1 reference

Europe PubMed Central

11 August 2017

Andrew M Lowy

6

1 reference

Europe PubMed Central

11 August 2017

Charles R Thomas

7

1 reference

Europe PubMed Central

11 August 2017

Laura A Dawson

9

1 reference

Europe PubMed Central

11 August 2017

Kenneth C Micetich

10

1 reference

Europe PubMed Central

11 August 2017

Melanie B Thomas

11

1 reference

Europe PubMed Central

11 August 2017

Abby B Siegel

12

1 reference

Europe PubMed Central

11 August 2017

Charles D Blanke

13

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

11 May 2015

1 reference

Europe PubMed Central

11 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

11 August 2017

33

1 reference

Europe PubMed Central

11 August 2017

24

1 reference

Europe PubMed Central

11 August 2017

2617-2622

1 reference

Europe PubMed Central

11 August 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

External-beam radiotherapy for localized extrahepatic cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Predictors of long-term survival in patients with gallbladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Improved survival in resected biliary malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Gallbladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

11 July 2018

Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

11 July 2018

Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2014.60.2219

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35947011&oldid=1968634959"